TCL Archive MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building. May 12, 2006
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive In Brief: Sporn Wins BMS Cancer Research Award; Dana-Farber To Try To Affect Teen Health April 3, 1998